These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26065500)

  • 1. Topical 5% Natamycin With Oral Ketoconazole in Filamentous Fungal Keratitis: A Randomized Controlled Trial.
    Rajaraman R; Bhat P; Vaidee V; Maskibail S; Raghavan A; Sivasubramaniam S; Namperumalsamy VP
    Asia Pac J Ophthalmol (Phila); 2015; 4(3):146-50. PubMed ID: 26065500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Oral Voriconazole Versus Oral Ketoconazole as an Adjunct to Topical Natamycin in Severe Fungal Keratitis: A Randomized Controlled Trial.
    Sharma N; Singhal D; Maharana PK; Sinha R; Agarwal T; Upadhyay AD; Velpandian T; Satpathy G; Titiyal JS
    Cornea; 2017 Dec; 36(12):1521-1527. PubMed ID: 28902012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.
    Sharma N; Chacko J; Velpandian T; Titiyal JS; Sinha R; Satpathy G; Tandon R; Vajpayee RB
    Ophthalmology; 2013 Apr; 120(4):677-81. PubMed ID: 23246119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical 5% Natamycin With Oral Ketoconazole in Filamentous Fungal Keratitis: A Randomized Controlled Trial.
    Rajaraman R
    Asia Pac J Ophthalmol (Phila); 2015; 4(6):399. PubMed ID: 26716437
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical 5% Natamycin With Oral Ketoconazole in Filamentous Fungal Keratitis: A Randomized Controlled Trial.
    Ravuri S; Mittal R; Bagga B
    Asia Pac J Ophthalmol (Phila); 2015; 4(6):399. PubMed ID: 26716436
    [No Abstract]   [Full Text] [Related]  

  • 6. Management Algorithm for Fungal Keratitis: The TST (Topical, Systemic, and Targeted Therapy) Protocol.
    Sharma N; Sahay P; Maharana PK; Singhal D; Saluja G; Bandivadekar P; Chako J; Agarwal T; Sinha R; Titiyal JS; Satpathy G; Velpandian T
    Cornea; 2019 Feb; 38(2):141-145. PubMed ID: 30334872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis.
    Prajna NV; John RK; Nirmalan PK; Lalitha P; Srinivasan M
    Br J Ophthalmol; 2003 Oct; 87(10):1235-7. PubMed ID: 14507756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.
    Sharma S; Das S; Virdi A; Fernandes M; Sahu SK; Kumar Koday N; Ali MH; Garg P; Motukupally SR
    Br J Ophthalmol; 2015 Sep; 99(9):1190-5. PubMed ID: 25740805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Linking-Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis.
    Prajna NV; Radhakrishnan N; Lalitha P; Austin A; Ray KJ; Keenan JD; Porco TC; Lietman TM; Rose-Nussbaumer J
    Ophthalmology; 2020 Feb; 127(2):159-166. PubMed ID: 31619359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
    Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Prajna L; Srinivasan M; Raghavan A; Oldenburg CE; Ray KJ; Zegans ME; McLeod SD; Porco TC; Acharya NR; Lietman TM;
    JAMA Ophthalmol; 2013 Apr; 131(4):422-9. PubMed ID: 23710492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
    Arora R; Gupta D; Goyal J; Kaur R
    Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
    Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Devi L; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2017 Jun; 135(6):520-525. PubMed ID: 28426856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis.
    Kalavathy CM; Parmar P; Kaliamurthy J; Philip VR; Ramalingam MD; Jesudasan CA; Thomas PA
    Cornea; 2005 May; 24(4):449-52. PubMed ID: 15829804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined application of 5% natamycin and 0.2% fluconazole for the treatment of fungal keratitis.
    Gong H; Gong X
    Eye Sci; 2013 Jun; 28(2):84-7. PubMed ID: 24396961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycotic Antimicrobial Localized Injection: A Randomized Clinical Trial Evaluating Intrastromal Injection of Voriconazole.
    Narayana S; Krishnan T; Ramakrishnan S; Samantaray PP; Austin A; Pickel J; Porco T; Lietman T; Rose-Nussbaumer J
    Ophthalmology; 2019 Aug; 126(8):1084-1089. PubMed ID: 30904540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical results of topical fluconazole for the treatment of filamentous fungal keratitis.
    Sonego-Krone S; Sanchez-Di Martino D; Ayala-Lugo R; Torres-Alvariza G; Ta CN; Barbosa L; de Kaspar HM
    Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):782-7. PubMed ID: 16133016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.
    Hoffman JJ; Yadav R; Sanyam SD; Chaudhary P; Roshan A; Singh SK; Singh SK; Mishra SK; Arunga S; Hu VH; Macleod D; Leck A; Burton MJ
    Ophthalmology; 2022 May; 129(5):530-541. PubMed ID: 34896126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.
    Prajna NV; Krishnan T; Rajaraman R; Patel S; Srinivasan M; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Porco TC; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2016 Dec; 134(12):1365-1372. PubMed ID: 27787540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole.
    Rose-Nussbaumer J; Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; Porco TC; McLeod SD; Acharya NR; Keenan JD; Lietman TM;
    Br J Ophthalmol; 2016 Jul; 100(7):929-932. PubMed ID: 26531051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Aspergillus fumigatus keratitis in rabbits with oral and topical ketoconazole.
    Komadina TG; Wilkes TD; Shock JP; Ulmer WC; Jackson J; Bradsher RW
    Am J Ophthalmol; 1985 Apr; 99(4):476-9. PubMed ID: 3872596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.